US5340585A
(en)
*
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Method and formulations for use in treating benign gynecological disorders
|
US5340586A
(en)
*
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5460820B1
(en)
|
1993-08-03 |
1999-08-03 |
Theratech Inc |
Method for providing testosterone and optionally estrogen replacement therapy to women
|
NZ275615A
(en)
*
|
1993-09-29 |
1996-11-26 |
Alza Corp |
Oxybutynin composition containing monoglyceride and lactate ester as permeability enhancers; device for transdermal administration of oxybutynin
|
DE4344462C2
(de)
*
|
1993-12-22 |
1996-02-01 |
Schering Ag |
Zusammensetzung für die Empfängnisverhütung
|
US5658884A
(en)
*
|
1994-07-22 |
1997-08-19 |
The Medical College Of Hampton Roads |
Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
|
ATE190494T1
(de)
*
|
1994-07-22 |
2000-04-15 |
Hampton Roads Medical College |
Verwendung von gnrh-antagonisten zur herstellung eines medikaments zur behandlung gonaden-steroid abhängiger erkrankungen
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
AUPN366795A0
(en)
|
1995-06-20 |
1995-07-13 |
Peptide Technology Limited |
Formulation for preventing reproductive function
|
FR2747042B1
(fr)
*
|
1996-04-05 |
1998-06-05 |
Besins Iscovesco Lab |
Medicament a base de progesterone et d'oestradiol
|
US6139873A
(en)
*
|
1996-07-10 |
2000-10-31 |
Cedars-Sinai Medical Center |
Combined pharmaceutical estrogen-androgen-progestin
|
US5770226A
(en)
*
|
1996-07-10 |
1998-06-23 |
Wake Forest University |
Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
|
DE69737635T2
(de)
*
|
1996-08-30 |
2008-01-03 |
Peptech Ltd., North Ryde |
Formulierung zur verzögerten Freisetzung von Peptidagonisten und -analoga des GnRH
|
SK116199A3
(en)
*
|
1997-02-28 |
2000-01-18 |
Minnesota Mining & Mfg |
Transdermal device for the delivery of testosterone
|
AU1518900A
(en)
*
|
1998-11-12 |
2000-06-05 |
Warner Chilcott Laboratories Ireland Limited |
Graduated progestin contraceptive
|
US6498153B1
(en)
|
1998-12-31 |
2002-12-24 |
Akzo Nobel N.V. |
Extended release growth promoting two component composition
|
DE60141145D1
(fi)
*
|
2000-08-24 |
2010-03-11 |
Sidney Lerner |
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
CA2427731A1
(en)
*
|
2000-10-30 |
2002-05-10 |
University Of Zurich |
Gnrh analogues for treatment of urinary incontinence
|
US20020107230A1
(en)
*
|
2000-12-22 |
2002-08-08 |
Waldon R. Forrest |
Methods and formulations for the treatment of female sexual dysfunction
|
DE10105592A1
(de)
*
|
2001-02-06 |
2002-08-08 |
Achim Goepferich |
Platzhalter zur Arzneistofffreigabe in der Stirnhöhle
|
US20020188170A1
(en)
*
|
2001-04-27 |
2002-12-12 |
Santamore William P. |
Prevention of myocardial infarction induced ventricular expansion and remodeling
|
EP1287817A1
(en)
*
|
2001-08-31 |
2003-03-05 |
Pantarhei Bioscience B.V. |
Method of treating uterine leiomyomas and intravaginal drug delivery vehicle for use in such method
|
US8048869B2
(en)
*
|
2001-05-18 |
2011-11-01 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
EP1260225A1
(en)
*
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
EP1390042B1
(en)
*
|
2001-05-23 |
2007-11-28 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
CA2448273C
(en)
*
|
2001-05-23 |
2010-06-29 |
Christian Franz Holinka |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
CA2451187C
(en)
*
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
WO2003018026A1
(en)
*
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
WO2003017974A1
(en)
*
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
|
US7658926B2
(en)
*
|
2001-09-14 |
2010-02-09 |
Opexa Pharmaceuticals, Inc. |
Autologous T-cell vaccines materials and methods
|
WO2003041719A1
(en)
*
|
2001-11-15 |
2003-05-22 |
Pantarhei Bioscience B.V. |
Method of contraception in mammalian females and pharmaceutical kit for use in such method
|
DK1446128T3
(da)
*
|
2001-11-15 |
2007-04-02 |
Pantarhei Bioscience Bv |
Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
|
DE60218881T2
(de)
*
|
2001-11-15 |
2007-12-20 |
Pantarhei Bioscience B.V. |
Verfahren zur vorbeugung oder behandlung von benignen gynäkologischen störungen
|
SI1453521T1
(sl)
*
|
2001-12-05 |
2013-11-29 |
Teva Women's Health, Inc. |
Oralni kontraceptiki za preprečevanje nosečnosti in zmanjševanje predmenstrualne simptomatike
|
US20030191096A1
(en)
*
|
2002-04-03 |
2003-10-09 |
Leonard Thomas W. |
Method of hormonal therapy
|
US7943604B2
(en)
*
|
2002-06-11 |
2011-05-17 |
Pantarhei Bioscience B.V. |
Method of treating human skin and a skin care composition for use in such a method
|
PT1511496E
(pt)
*
|
2002-06-11 |
2007-01-31 |
Pantarhei Bioscience Bv |
Método para tratamento ou prevenção de doenças mediadas pelo sistema imunitário e formulação farmacológica para utilização nas mesmas
|
DK1526856T3
(da)
|
2002-07-12 |
2008-03-10 |
Pantarhei Bioscience Bv |
Farmaceutisk sammensætning omfattende estetrolderivater til anvendelse i cancerterapi
|
US6960337B2
(en)
*
|
2002-08-02 |
2005-11-01 |
Balance Pharmaceuticals, Inc. |
Methods and compositions for treating benign gynecological disorders
|
US7029657B2
(en)
*
|
2002-08-02 |
2006-04-18 |
Balance Pharmaceuticals, Inc. |
Nasal spray steroid formulation and method
|
US6958142B2
(en)
*
|
2002-08-02 |
2005-10-25 |
Balance Pharmaceuticals, Inc. |
Nasal spray formulation and method
|
ES2537951T3
(es)
*
|
2002-08-08 |
2015-06-16 |
Baylor College Of Medicine |
Aislamiento e identificación de células T
|
US8317816B2
(en)
|
2002-09-30 |
2012-11-27 |
Acclarent, Inc. |
Balloon catheters and methods for treating paranasal sinuses
|
DK1556058T3
(da)
*
|
2002-10-23 |
2008-03-03 |
Pantarhei Bioscience Bv |
Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
|
CU23204A1
(es)
*
|
2002-12-27 |
2007-05-18 |
Ct Ingenieria Genetica Biotech |
Combinaciones de factores reguladores del crecimiento y hormonas para el tratamiento de neoplasias
|
US20040266025A1
(en)
|
2003-02-06 |
2004-12-30 |
Durlin Hickok |
Screening and treatment methods for prevention of preterm delivery
|
WO2004096151A2
(en)
*
|
2003-04-29 |
2004-11-11 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
WO2004096259A1
(en)
*
|
2003-04-30 |
2004-11-11 |
Debiopharm S.A. |
Methods and compositions using gonadotropin hormone releasing hormone
|
PT1624878E
(pt)
*
|
2003-05-22 |
2007-01-31 |
Pantarhei Bioscience Bv |
Utilização de composições que compreendem um componente estrogénico para o tratamento e prevenção da dor musculoesquelética
|
DK1663161T3
(en)
*
|
2003-06-13 |
2015-04-27 |
Skendi Finance Ltd |
Slow release estradiol progesterone formulation
|
US8399013B2
(en)
*
|
2003-06-26 |
2013-03-19 |
Poly-Med, Inc. |
Partially absorbable fiber-reinforced composites for controlled drug delivery
|
US8404272B2
(en)
|
2003-06-26 |
2013-03-26 |
Poly-Med, Inc. |
Fiber-reinforced composite rings for intravaginal controlled drug delivery
|
CA2771944A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Teva Women's Health, Inc. |
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
|
KR20060129175A
(ko)
*
|
2003-10-01 |
2006-12-15 |
얀센 파마슈티카 엔.브이. |
확장된 3상 피임 요법
|
WO2005063276A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Debiopharm S.A. |
Methods and compositions using gonadotropin hormone releasing hormone
|
US9399121B2
(en)
|
2004-04-21 |
2016-07-26 |
Acclarent, Inc. |
Systems and methods for transnasal dilation of passageways in the ear, nose or throat
|
US20070167682A1
(en)
|
2004-04-21 |
2007-07-19 |
Acclarent, Inc. |
Endoscopic methods and devices for transnasal procedures
|
US8764729B2
(en)
|
2004-04-21 |
2014-07-01 |
Acclarent, Inc. |
Frontal sinus spacer
|
US7410480B2
(en)
|
2004-04-21 |
2008-08-12 |
Acclarent, Inc. |
Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
|
US10188413B1
(en)
|
2004-04-21 |
2019-01-29 |
Acclarent, Inc. |
Deflectable guide catheters and related methods
|
US7654997B2
(en)
|
2004-04-21 |
2010-02-02 |
Acclarent, Inc. |
Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
|
US8932276B1
(en)
|
2004-04-21 |
2015-01-13 |
Acclarent, Inc. |
Shapeable guide catheters and related methods
|
US20060063973A1
(en)
|
2004-04-21 |
2006-03-23 |
Acclarent, Inc. |
Methods and apparatus for treating disorders of the ear, nose and throat
|
US8894614B2
(en)
|
2004-04-21 |
2014-11-25 |
Acclarent, Inc. |
Devices, systems and methods useable for treating frontal sinusitis
|
US8864787B2
(en)
|
2004-04-21 |
2014-10-21 |
Acclarent, Inc. |
Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
|
US7803150B2
(en)
|
2004-04-21 |
2010-09-28 |
Acclarent, Inc. |
Devices, systems and methods useable for treating sinusitis
|
US9101384B2
(en)
|
2004-04-21 |
2015-08-11 |
Acclarent, Inc. |
Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
|
US7462175B2
(en)
|
2004-04-21 |
2008-12-09 |
Acclarent, Inc. |
Devices, systems and methods for treating disorders of the ear, nose and throat
|
US8146400B2
(en)
|
2004-04-21 |
2012-04-03 |
Acclarent, Inc. |
Endoscopic methods and devices for transnasal procedures
|
US9554691B2
(en)
|
2004-04-21 |
2017-01-31 |
Acclarent, Inc. |
Endoscopic methods and devices for transnasal procedures
|
US20070208252A1
(en)
|
2004-04-21 |
2007-09-06 |
Acclarent, Inc. |
Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
|
US20060004323A1
(en)
|
2004-04-21 |
2006-01-05 |
Exploramed Nc1, Inc. |
Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
|
US7419497B2
(en)
|
2004-04-21 |
2008-09-02 |
Acclarent, Inc. |
Methods for treating ethmoid disease
|
US8747389B2
(en)
|
2004-04-21 |
2014-06-10 |
Acclarent, Inc. |
Systems for treating disorders of the ear, nose and throat
|
US8702626B1
(en)
|
2004-04-21 |
2014-04-22 |
Acclarent, Inc. |
Guidewires for performing image guided procedures
|
US20190314620A1
(en)
|
2004-04-21 |
2019-10-17 |
Acclarent, Inc. |
Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
|
US9089258B2
(en)
|
2004-04-21 |
2015-07-28 |
Acclarent, Inc. |
Endoscopic methods and devices for transnasal procedures
|
US7361168B2
(en)
|
2004-04-21 |
2008-04-22 |
Acclarent, Inc. |
Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
|
US7559925B2
(en)
|
2006-09-15 |
2009-07-14 |
Acclarent Inc. |
Methods and devices for facilitating visualization in a surgical environment
|
US9351750B2
(en)
|
2004-04-21 |
2016-05-31 |
Acclarent, Inc. |
Devices and methods for treating maxillary sinus disease
|
BRPI0513141A
(pt)
*
|
2004-07-09 |
2008-04-29 |
Population Council Inc |
composição para anel vaginal, e, processo de contracepção a longo prazo
|
CA2575675A1
(en)
|
2004-07-30 |
2006-03-09 |
Adeza Biomedical Corporation |
Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
|
US20070111975A1
(en)
*
|
2004-10-07 |
2007-05-17 |
Duramed Pharmaceuticals, Inc. |
Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
|
US20060100566A1
(en)
*
|
2004-11-05 |
2006-05-11 |
Women's Medical Research Group, Llc |
Apparatus and method for the treatment of dysmenorrhea
|
US8951225B2
(en)
|
2005-06-10 |
2015-02-10 |
Acclarent, Inc. |
Catheters with non-removable guide members useable for treatment of sinusitis
|
US10137135B2
(en)
*
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
US8114113B2
(en)
|
2005-09-23 |
2012-02-14 |
Acclarent, Inc. |
Multi-conduit balloon catheter
|
GEP20125432B
(en)
|
2005-10-12 |
2012-03-26 |
Unimed Pharmaceuticals Llc |
Improved testosterone gel and use thereof
|
NZ572644A
(en)
*
|
2006-05-05 |
2012-06-29 |
Opexa Therapeutics |
T-cell vaccine
|
US8190389B2
(en)
|
2006-05-17 |
2012-05-29 |
Acclarent, Inc. |
Adapter for attaching electromagnetic image guidance components to a medical device
|
US9820688B2
(en)
|
2006-09-15 |
2017-11-21 |
Acclarent, Inc. |
Sinus illumination lightwire device
|
US8439687B1
(en)
|
2006-12-29 |
2013-05-14 |
Acclarent, Inc. |
Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
|
EP2114412B1
(en)
*
|
2007-01-08 |
2010-07-14 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
US8118757B2
(en)
|
2007-04-30 |
2012-02-21 |
Acclarent, Inc. |
Methods and devices for ostium measurement
|
US8485199B2
(en)
|
2007-05-08 |
2013-07-16 |
Acclarent, Inc. |
Methods and devices for protecting nasal turbinate during surgery
|
US10206821B2
(en)
|
2007-12-20 |
2019-02-19 |
Acclarent, Inc. |
Eustachian tube dilation balloon with ventilation path
|
US8182432B2
(en)
|
2008-03-10 |
2012-05-22 |
Acclarent, Inc. |
Corewire design and construction for medical devices
|
US9034365B2
(en)
|
2008-05-20 |
2015-05-19 |
Poly-Med, Inc. |
Biostable, multipurpose, microbicidal intravaginal devices
|
MX2011001099A
(es)
|
2008-07-30 |
2011-03-15 |
Acclarent Inc |
Metodos y dispositivos localizadores de ostium paranasal.
|
EP2323724A1
(en)
|
2008-09-18 |
2011-05-25 |
Acclarent, Inc. |
Methods and apparatus for treating disorders of the ear nose and throat
|
US20100241155A1
(en)
|
2009-03-20 |
2010-09-23 |
Acclarent, Inc. |
Guide system with suction
|
US8435290B2
(en)
|
2009-03-31 |
2013-05-07 |
Acclarent, Inc. |
System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
|
US7978742B1
(en)
|
2010-03-24 |
2011-07-12 |
Corning Incorporated |
Methods for operating diode lasers
|
US9155492B2
(en)
|
2010-09-24 |
2015-10-13 |
Acclarent, Inc. |
Sinus illumination lightwire device
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
HRP20211377T1
(hr)
|
2011-11-23 |
2022-01-07 |
Therapeuticsmd, Inc. |
Prirodne kombinirane hormonske supstitucijske formulacije i terapije
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
KR101586791B1
(ko)
*
|
2012-12-28 |
2016-01-19 |
주식회사 종근당 |
GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
|
US9433437B2
(en)
|
2013-03-15 |
2016-09-06 |
Acclarent, Inc. |
Apparatus and method for treatment of ethmoid sinusitis
|
US9629684B2
(en)
|
2013-03-15 |
2017-04-25 |
Acclarent, Inc. |
Apparatus and method for treatment of ethmoid sinusitis
|
US9433763B2
(en)
|
2013-09-27 |
2016-09-06 |
Acclarent, Inc. |
Sinus wall implant
|
CA2947767A1
(en)
|
2014-05-22 |
2015-11-26 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9844558B1
(en)
|
2015-04-30 |
2017-12-19 |
Amag Pharmaceuticals, Inc. |
Methods of reducing risk of preterm birth
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
JP2019513709A
(ja)
|
2016-04-01 |
2019-05-30 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
ステロイドホルモン薬学的組成物
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
EP3458070A4
(en)
*
|
2016-05-16 |
2020-01-08 |
Amag Pharmaceuticals, Inc. |
PROLONGED RELEASE POLYMER COMPOSITIONS BASED ON HYDROXYPROGESTERONE CAPROATE AND METHODS OF USE THEREOF
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|